Melissa Albersheim

Melissa Albersheim

Auto-generated profile, based on publicly available information

Melissa Albersheim

Department of Orthopaedic Surgery, University of Minnesota, Minneapolis, Minnesota

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2020 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
WFWilliam Fedje-Johnston
William Fedje-Johnston
FTFerenc Tóth
Ferenc Tóth
MAMelissa Albersheim
Melissa Albersheim
CCCathy S. Carlson
Cathy S. Carlson
KSKevin G. Shea
Kevin G. Shea
MTMarc Tompkins
Marc Tompkins
Background: Treatment of meniscal tears is necessary to maintain the long-term health of the knee joint. Morphological elements, particularly vascularity, that play an important role in meniscal healing are known to change during skeletal development. Purpose: To quantitatively evaluate meniscal vascularity, cellularity, collagen, and proteoglycan content by age and location during skeletal development. Study Design: Descriptive laboratory study. Methods: Medial and lateral menisci from 14 male and 7 female cadavers aged 1 month to 11 years were collected and evaluated. For each meniscus, histologic and immunohistologic techniques were used to establish the ratio of the area of proteoglycan (safranin O) positivity to the total area (proteoglycan ratio), collagen type I and type II immunostaining positivity, number of blood vessels, and cell density. These features were evaluated over the entire meniscus and also separately in 5 circumferential segments: anterior root, anterior horn, body, posterior horn, and posterior root. Additionally, cell density and number of blood vessels were examined in 3 radial regions: inner, middle, and periphery. Results: Age was associated with a decrease in meniscal vessel count and cell density, while the proteoglycan ratio increased with skeletal maturity. Differences in vessel counts, cellular density, and proteoglycan ratio in different anatomic segments as well as in the inner, middle, and peripheral regions of the developing menisci were also observed. Collagen immunostaining results were inconsistent and not analyzed. Conclusion: The cellularity and vascularity of the developing meniscus decrease with age and the proteoglycan content increases with age. All of these parameters are influenced by location within the meniscus. Clinical Relevance: Age and location differences in meniscal morphology, particularly in the number of blood vessels, are expected to influence meniscal healing.

1 September 2020 in JAAOS: Global Research and Reviews
Verified
Journal Article
Open access
BWBenjamin R. Williams
Benjamin R. Williams
DMDylan L. McCreary
Dylan L. McCreary
HPHarsh R. Parikh
Harsh R. Parikh
MAMelissa S. Albersheim
Melissa S. Albersheim
BCBrian P. Cunningham
Brian P. Cunningham
He outcomes between upper and lower extremity implant removal, and (3) determine the rate of implant removal complications. Methods: A prospective study was conducted between 2013 and 2016. Patients completed a Short Musculoskeletal Function Assessment outcome questionnaire before implant removal and at the 6-month follow-up. Demographic data were stratified and compared between upper and lower extremity groups and between preimplant removal and 6-month postremoval. Results: Of the 119 patients included in the study, 85 (71.4%) were lower extremity and 34 (28.6%) were upper extremity. Significant improvement after implant removal was seen in the dysfunction index (P ≤ 0.001), bother index (P ≤ 0.001), and daily activities domain (P ≤ 0.001). Depression or anxiety (P = 0.016) were statistically significant predictors for an improved Short Musculoskeletal Function Assessment dysfunction index score at 6 months. The complication rate was 10.1% (n=12) for the cohort. Discussion: Implant removal in both the upper and lower extremity presented notable improvement in dysfunction. Complications that require surgical intervention are extremely rare....

1 August 2021 in Injury
Verified
Journal Article
Closed access
IFIlexa R. Flagstad
Ilexa R. Flagstad
LTLauren M. Tatman
Lauren M. Tatman
MAMelissa Albersheim
Melissa Albersheim
AHAustin Heare
Austin Heare
HPHarsh R. Parikh
Harsh R. Parikh
BCBrian Cunningham
Brian Cunningham

31 July 2020 in Current Orthopaedic Practice
Verified
Journal Article
Closed access
MAMelissa Albersheim
Melissa Albersheim
HPHarsh R. Parikh
Harsh R. Parikh
SPSarah C. Bs Peck
Sarah C. Bs Peck
JLJackson S. Bs Lindell
Jackson S. Bs Lindell
SVSandy Ba Vang
Sandy Ba Vang
BCBrian P. Cunningham
Brian P. Cunningham
Background: Few studies to date have investigated healthcare administrators’ knowledge of implant costs, and, to the authors’ knowledge, none have evaluated surgeons’ knowledge of implant costs comparing their own cases to a general cohort. The purpose of this study was to analyze cost perceptions surrounding orthopaedic implants across subspecialties within a cohort of musculoskeletal surgeons and healthcare administrators. Methods: A 10-question survey, consisting of 10 fracture patients with their associated postoperative radiographs and the corresponding implant list, was distributed to administrators and musculoskeletal surgeons at a single Level I trauma hospital. Surgeons and administrators were asked to estimate the total cost of each of the constructs given on the survey. The estimates were subtracted from the actual implant costs, with average cost differences assessed as a net value for cohorts, surgeon specialties, and question type. Results: Administrators averaged an overestimation of $4655.22/case and surgeons averaged an overestimation of $41.61/case. The surgeon cohort averaged an underestimation of $608.06/case for their subspecialty cases and an underestimation of $3160.07/case for the control cases, neurosurgeons excluded. Traumatologists averaged an underestimation of $381.24/case overall, an underestimation of $379.72/case for their subspecialty cases, and an underestimation of $13.06/case for control cases. Conclusions: This study identified that neither surgeons nor administrators could accurately estimate implant costs. Orthopaedic surgeons appeared more accurate and may be uniquely positioned to interface with administrators. Although our study was limited by a small sample size, it pointed to opportunity for collaboration between surgeons and administrators to better understand implant costs and maximize value. Level of Evidence: Level VI.

10 April 2024 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MAMelissa Albersheim
Melissa Albersheim
FHFernando A. Huyke-Hernández
Fernando A. Huyke-Hernández
SDStephen A. Doxey
Stephen A. Doxey
HPHarsh R. Parikh
Harsh R. Parikh
ABAllison L. Boden
Allison L. Boden
BCBrian P. Cunningham
Brian P. Cunningham
Background: Insertion of a skeletal traction pin in the distal femur or proximal tibia can be a painful and unpleasant experience for patients with a lower-extremity fracture. The purpose of this study was to determine whether providing patients with audio distraction (AD) during traction pin insertion can help to improve the patient-reported and the physician-reported experience and decrease pain and/or anxiety during the procedure. Methods: A prospective randomized controlled trial was conducted at 2 level-I trauma centers. Patients ≥18 years of age who were conscious and oriented and had a medical need for skeletal traction were included. Patients were randomized to receive AD or not receive AD during the procedure. All other procedure protocols were standardized and were the same for both groups. Surveys were completed by the patient and the physician immediately following the procedure. Patients rated their overall experience, pain, and anxiety during the procedure, and physicians rated the difficulty of the procedure, both on a 1-to-10 Likert scale. Results: A total of 54 patients met the inclusion criteria. Twenty-eight received AD and 26 did not. Femoral fractures were the most common injury (33 of 55, 60.0%). Baseline demographic characteristics did not differ between the 2 groups. The overall patient-reported procedure experience was similar between the AD and no-AD groups (3.9 ± 2.9 [95% confidence interval (CI), 3.1 to 4.7] versus 3.5 ± 2.2 [95% CI, 2.9 to 4.1], respectively; p = 0.55), as was pain (5.3 ± 3.2 [95% CI, 4.4 to 6.2] versus 6.1 ± 2.4 [95% CI, 5.4 to 6.8]; p = 0.28). However, anxiety levels were lower in the AD group (4.8 ± 3.3 [95% CI, 3.9 to 5.7] versus 7.1 ± 2.8 [95% CI, 6.3 to 7.9]; p = 0.007). Physician-reported procedure difficulty was similar between the groups (2.6 ± 2.0 [95% CI, 2.1 to 3.1] versus 2.8 ± 1.7 [95% CI, 2.3 to 3.3]; p = 0.69). Conclusions: AD is a practical, low-cost intervention that may reduce patient anxiety during lower-extremity skeletal traction pin insertion. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.